Olga Viktorovna Lagoda

Olga Viktorovna Lagoda

Auto-generated profile, based on publicly available information

Olga Viktorovna Lagoda

Research Center of Neurology

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 January 2015 in Journal of the Neurological Sciences
Verified
Journal Article
Closed access
PDF file
NANatalya Abramycheva
Natalya Abramycheva
MSMaria Stepanova
Maria Stepanova
LKLyudmila Kalashnikova
Lyudmila Kalashnikova
MZMaria Zakharova
Maria Zakharova
MMMarina Maximova
Marina Maximova
SISergey Illarioshkin
Sergey Illarioshkin

6 March 2024 in Obesity and metabolism
Verified
Journal Article
Open access
PDF file
KAK. V. Antonova
K. V. Antonova
MTMarine Tanashyan
Marine Tanashyan
ARAnton Alekseevich Raskurazhev
Anton Alekseevich Raskurazhev
NSN. E. Spryshkov
N. E. Spryshkov
APA. A. Panina
A. A. Panina
ETEkaterina Troshina
Ekaterina Troshina
The article discusses certain aspects of the relationship between neurological diseases and metabolic disorders that are extremely relevant in connection with the pandemic spread of obesity. The pathogenesis of damage to the nervous system (NS) is considered in detail. The influence of the main metabolic factors on the development of cerebrovascular diseases (CVD), incl. neuroinflammation, changes in hemostasis, etc. is demonstrated. The problem of the development of cognitive dysfunction against the background of obesity due to the formation of atrophic processes in brain structures is highlighted. Modern possibilities of evaluation and modulation of eating behavior due to brain stimulation using functional magnetic resonance imaging (fMRI) and navigational rhythmic transcranial magnetic stimulation (rTMS) are described.The problem of cerebrometabolic health is presented as a continuum of metabolic and cerebral disturbances. The mechanisms of interaction between the two most important systems of the body allow us to consider the changes that occur in them as an integral neuroendocrine alteration.

7 September 2016 in Cerebrovascular Diseases Extra
Verified
Journal Article
Open access
PDF file
MTMarine Tanashyan
Marine Tanashyan
Polina Igorevna KuznetsovaPolina Igorevna Kuznetsova
Polina Igorevna Kuznetsova
ASAlla A. Shabalina
Alla A. Shabalina
ARAnton Alekseevich Raskurazhev
Anton Alekseevich Raskurazhev
OLOlga V. Lagoda
Olga V. Lagoda
AMAnait L. Melikyan
Anait L. Melikyan
Background: Disturbances of microcirculation play a significant role in the development and progression of both acute and chronic cerebrovascular diseases (CVD) and may be associated with different hemogram abnormalities. One of the reasons of the prothrombogenic state of the endothelium is the increase in the number of blood corpuscles leading to (non-Ph) myeloproliferative disorders (MPD) including essential thrombocythemia (ET), polycythemia vera (PV), and primary myelofibrosis (PM). Materials and Methods: The study included 167 patients: 102 patients with Ph-MPD and the control group comprising 65 patients with CVD. According to MPD subtype, the patients were divided into three groups: patients with ET (37%, n = 38, male/female 7/31, age 52 ± 7 years), those with PV (40%, n = 41, male/female 20/21, age 50 ± 6 years) and those with PM (23%, n = 23, male/female 5/18, age 54 ± 4 years). Results: In 79% (n = 81) of cases in the study group (with Ph-MPD), patients had chronic CVD, with the most frequently identified symptoms being asthenia (92%) and headache (72%). Headache in Ph-MPD patients was more frequently (86%) associated with PM, while in patients with PV and ET it was equally distributed (70%). Neurological symptoms in 53% of cases were associated with focal changes of the brain on MRI localized in the subcortical area of the frontal and parietal lobes. Twenty-one (21%) patients suffered an acute cerebrovascular accident, 8 of them had thrombotic occlusion of one of the internal carotid arteries leading to hemispheric infarcts. Endothelial function (as measured by flow-dependent dilation of the brachial artery) was severely impaired in all study groups (median 5% with normal cut-off at 10%), the lowest degree of vasodilator activity being specific for patients with a history of stroke (p = 0.011). Conclusion: Patients suffering from MPD had asymptomatic focal changes in the brain in the absence of concomitant vascular disease (hypertension, atherosclerotic vascular disease, heart rhythm disorders) in 50% of cases. MPD, while remaining un- or underdiagnosed, presents a major concern in the cerebrovascular setting. A large number of thrombotic strokes occurring in patients with ET underline the necessity of early diagnostics and preventive therapy in these patients.

1 January 2015 in S.S. Korsakov Journal of Neurology and Psychiatry
Verified
Journal Article
Closed access
MTMarine Tanashyan
Marine Tanashyan
OLO. V. Lagoda
O. V. Lagoda
KAK. V. Antonova
K. V. Antonova
Metabolic syndrome is a serious risk factor for acute and chronic cerebrovascular disease, which are a leading cause of disabling conditions. The association of proatherogenic effects of the main components of metabolic syndrome--hyperinsulinemia, arterial hypertension, dyslipidemia and obesity--leads to prominent haemorheological and hemostasis changes, which in turn play a pivotal role in the initiation, course and outcome of cerebrovascular pathology. Metabolic syndrome also influences the efficacy of the main pathogenetic therapy of cerebrovascular diseases--antithrombotic therapy. Thus, primary and secondary prevention of cerebrovascular disease in patients with metabolic syndrome should include haemangiocorrective, antithrombotic, antioxidant and endothelium-protective treatment, as well as therapy of the main components of metabolic syndrome.

28 July 2018 in Obesity and metabolism
Verified
Journal Article
Open access
OLOksana Viktorovna Logvinova
Oksana Viktorovna Logvinova
APAlexandra Poydasheva
Alexandra Poydasheva
IBIlya Bakulin
Ilya Bakulin
OLOlga Viktorovna Lagoda
Olga Viktorovna Lagoda
EKElena Kremneva
Elena Kremneva
MPMichael Piradov
Michael Piradov
The present review considers modern concepts of the physiological mechanisms of the formation of food behavior in a norm at several levels, beginning with the cellular level and ending with the level of functional systems. Neuroimaging methods used for both the study of the pathophysiological foundations of eating disorders and for determining the target for neurostimulation techniques are described. Methods of non-invasive brain stimulation such as transcranial magnetic stimulation and transcranial electrical stimulation, the mechanisms of their influence and aspects of safety of application are reviewed, the latest data on the results of studies on the use of the above methods in the therapy of obesity are summarized.

4 October 2021 in Annals of Clinical and Experimental Neurology
Verified
Journal Article
Open access
PDF file
MTMarine Tanashyan
Marine Tanashyan
KAKseniya V. Antonova
Kseniya V. Antonova
ОLОlga V. Lagoda
Оlga V. Lagoda
АSАlla А. Shabalina
Аlla А. Shabalina
Significant contribution of type 2 diabetes mellitus (T2DM) to the development and progression of cerebrovascular disease (CVD) has been confirmed over the past few decades. The aim of this article is to present the results of many years of research, summarizing generally resolved problems in CVD and T2DM comorbidity, as well as raising several issues that still need to be clarified. Materials and methods. The assessment results of 824 patients with CVD were selected from a large body of data for inclusion in the analysis. Ischaemic stroke was analysed in 250 patients: 128 patients with T2DM (aged 63 [54; 74] years) and 122 patients without T2DM (62 [52; 71] years). The group with chronic CVD consisted of 574 people: 300 patients with T2DM (62 [56; 69] years) and 274 patients without T2DM (63 [57; 68] years). The results of surgery for carotid artery stenosis were evaluated in 170 patients, including 72 patients with T2DM. The control group consisted of 86 persons without CVD (60 [54; 63] years). A wide range of clinical, laboratory and imaging assessments included physical and neurological examinations, neuropsychological tests, blood chemistry, haemorheological and haemostasis tests, as well as neuroimaging studies. Results. T2DM has a significant effect on neurological, neuropsychological, cognitive and functional impairments, as well as on the outcome of acute and chronic CVD, progression of intracranial atherosclerotic lesions, and changes in cerebral and vascular tissue. The impact of the quality of glycaemic control and duration of chronic hyperglycaemia on neurocognitive and structural brain changes has not been completely determined yet. The role of non-glycaemic changes, including influence of several mediators on the vascular and neurodegenerative mechanisms of cerebral tissue damage, warrants further study. Conclusion. The obtained results identify a wide range of unanswered questions and emphasize the need for both possible changes to several clinical algorithms and for ongoing in-depth studies of CVD associated with T2DM.